Cancer drug development award given to Jean-Charles Soria

(European Society for Medical Oncology) The TAT 2018 Honorary Award for cancer drug development has been granted to Professor Jean-Charles Soria, for his pioneering role in cancer drug development across molecular targeted agents, precision medicine, and immunotherapy. The award will be presented during the International Congress on Targeted Anticancer Therapies (TAT) 2018, to be held in Paris, France, March 5-7.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news